| # | % | |||||
|---|---|---|---|---|---|---|
| 501 | ARES CAPITAL CORP | 10,162 | 144,000 | 0.00% | ||
| 502 | PROSHARES TR II | 5,600 | 140,000 | 0.00% | Call | |
| 503 | FRONTLINE LTD | 17,700 | 139,000 | 0.00% | ||
| 504 | SANOFI SPOND FUNSPONSORED ADR | 25,000 | 135,000 | 0.00% | ||
| 505 | CELLDEX THERAPEUTICS INC NEW | 26,335 | 115,000 | 0.00% | ||
| 506 | OSIRIS THERAPEUTICS INC NEW COM | 21,000 | 107,000 | 0.00% | ||
| 507 | VOYA PRIME RATE TR | 20,427 | 105,000 | 0.00% | ||
| 508 | MFS HIGH INCOME MUN TR | 16,762 | 92,000 | 0.00% | ||
| 509 | PENN WEST PETE LTD NEW | 62,562 | 87,000 | 0.00% | ||
| 510 | PACIFIC BIOSCIENCES CALIF IN | 12,000 | 84,000 | 0.00% | ||
| 511 | CVR REFNG LP | 10,204 | 79,000 | 0.00% | ||
| 512 | WEBMD HEALTH CORP | 72,000 | 79,000 | 0.00% | PRN | |
| 513 | Arena Pharmaceuticals, Inc | 45,000 | 77,000 | 0.00% | ||
| 514 | WESTERN ASSET MGD HI INCM FD | 14,400 | 68,000 | 0.00% | ||
| 515 | BLACKROCK DEBT STRAT FD INC COM | 17,960 | 63,000 | 0.00% | ||
| 516 | APOLLO INVT CORP | 11,249 | 62,000 | 0.00% | ||
| 517 | CHESAPEAKE ENERGY CORP | 48,000 | 44,000 | 0.00% | PRN | |
| 518 | LADENBURG THALMAN FIN SVCS I | 14,700 | 34,000 | 0.00% | ||
| 519 | Novacopper Inc | 31,958 | 16,000 | 0.00% | ||
| 520 | SYNTA PHARMACEUTICALS CORP | 18,000 | 5,000 | 0.00% | ||
| 521 | SANOFI | 15,940 | 4,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001527271-16-000008, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
